ACSH staffers welcome an article in the online journal, Medscape, reporting on the Natural Resources Defense Council’s (NRDC) suit against the FDA asking for a “writ of mandamus,” or court order requiring the agency to respond to NRDC’s 2008 petition to ban the use of BPA in commercial products.
In addition to calling the NRDC lawsuit “bizarre,” ACSH's Dr. Gilbert Ross was further quoted in the article:
ACSH staffers welcome an article in the online journal, Medscape, reporting on the Natural Resources Defense Council’s (NRDC) suit against the FDA asking for a “writ of mandamus,” or court order requiring the agency to respond to NRDC’s 2008 petition to ban the use of BPA in commercial products.
In addition to calling the NRDC lawsuit “bizarre,” ACSH's Dr. Gilbert Ross was further quoted in the article:
Every scientific body that has evaluated BPA has ruled that it is safe in the amounts that most people are exposed to in our environment. There’s no scientific basis for this crusade against BPA, and the lawsuit against the FDA is simply a way to get attention for the NRDC.
We couldn’t have said it better ourselves.
Click here and register for free to gain full access to the Medscape article.
